Diagnosis of Genetic Disorders Associated with the Chromosomal Abnormalities
Chromosomal abnormalities refer to deviations from the normal number or structure of chromosomes, the carriers of genetic information in cells. These abnormalities can result from errors in cell division, including nondisjunction, anaphase lag, or translocation, or from environmental factors such as radiation, chemicals, or viruses. They have significant impacts on human health, leading to various congenital malformations, developmental delays, intellectual disabilities, infertility, and an increased risk of cancer. Chromosomal abnormalities are broadly categorized into two main types: numerical abnormalities, involving changes in the number of chromosomes like aneuploidy or polyploidy, and structural abnormalities, involving changes in the shape or arrangement of chromosomes such as deletion, duplication, inversion, or translocation. The diagnosis of chromosomal abnormalities can be made through different methods, including chromosomal analysis (karyotyping), molecular genetics techniques like fluorescence in situ hybridization and microarray analysis, or biochemical testing such as enzyme assays and metabolite measurements.
Fig.1 Transmission of a genetic disease
Down Syndrome
Down syndrome, a genetic disorder, occurs when a person has an extra copy of chromosome 21, either in whole or in part. This additional chromosome affects the development and function of various organs and systems in the body, leading to physical, mental, and medical problems. Common features of Down syndrome include a distinctive facial appearance, short stature, low muscle tone, congenital heart defects, and increased susceptibility to infections. Individuals with Down syndrome also experience cognitive impairment, ranging from mild to moderate intellectual disability, and may have behavioral problems like attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), or depression. Furthermore, people with Down syndrome have a higher risk of developing certain diseases such as leukemia, Alzheimer's disease, thyroid dysfunction, and celiac disease. Diagnosis of Down syndrome can occur before or after birth through methods analyzing the number and structure of chromosomes in fetal or newborn cells. Although there is no cure for Down syndrome, treatments and interventions, including gene therapy, stem cell therapy, early intervention programs, special education, speech therapy, occupational therapy, physical therapy, social support, medication, surgery, and regular medical check-ups, can improve the quality of life and health outcomes for affected individuals.
Turner Syndrome
Turner syndrome, a genetic disorder affecting only females, is characterized by having one normal X chromosome and a missing or abnormal second sex chromosome. It occurs in about 1 in 2000 to 2500 live female births and results from a random error in cell division during gametogenesis or early embryonic development. The absence or abnormality of the sex chromosome affects the development and function of various organs and systems in the body, leading to physical, mental, and medical problems. Common features of Turner syndrome include short stature, a webbed neck, low hairline, low-set ears, broad chest, and underdeveloped ovaries. Women with Turner syndrome often experience cognitive impairment, particularly in visuospatial and mathematical skills, and may face social difficulties such as anxiety, shyness, or low self-esteem. Additionally, women with Turner syndrome have a higher risk of developing certain diseases, such as congenital heart defects, hypertension, kidney abnormalities, diabetes, thyroid dysfunction, and osteoporosis. Turner syndrome can be diagnosed before or after birth using methods that analyze the number and structure of chromosomes in fetal or newborn cells. While there is no cure for Turner syndrome, treatments and interventions, including growth hormone therapy, estrogen replacement therapy, cardiovascular intervention, fertility treatment, psychological support, and regular medical check-ups, can improve the quality of life and health outcomes for affected women.
Klinefelter Syndrome
Klinefelter syndrome, a genetic disorder affecting only males, is characterized by having one or more extra X chromosomes in addition to the normal XY pair. It occurs in about 1 in 500 to 1000 live male births and results from a random error in cell division during gametogenesis or early embryonic development. The presence of the extra X chromosome affects the development and function of various organs and systems in the body, leading to physical, mental, and medical problems. Common features of Klinefelter syndrome include tall stature, small testes, gynecomastia, reduced facial and body hair, and infertility. Men with Klinefelter syndrome often experience cognitive impairment, especially in language and executive skills, and may face behavioral problems such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), or depression. Additionally, men with Klinefelter syndrome have a higher risk of developing certain diseases, such as osteoporosis, diabetes, cardiovascular disease, breast cancer, and autoimmune disorders. Klinefelter syndrome can be diagnosed before or after birth using methods that analyze the number and structure of chromosomes in fetal or newborn cells. While there is no cure for Klinefelter syndrome, treatments and interventions, including testosterone replacement therapy, assisted reproductive technology, psychological support, and regular medical check-ups, can improve the quality of life and health outcomes for affected men.
Huntington's Disease
Huntington's disease is a rare inherited disease that causes the progressive breakdown and death of nerve cells in the brain, affecting approximately 1 in 10,000 people in the United States. It is caused by a mutation in a gene called HTT, which normally produces a protein called huntingtin. This mutation results in an abnormal form of huntingtin that accumulates and damages nerve cells, particularly in areas of the brain controlling movement, thinking, and emotions. Symptoms of Huntington's disease typically begin between ages 30 and 50 but can also occur earlier or later. These symptoms include involuntary jerking or twitching movements (chorea), muscle stiffness or spasms (dystonia), difficulty with walking, balance, speech, and swallowing, cognitive impairment such as memory loss, poor concentration, and impaired judgment, as well as psychiatric problems like depression, anxiety, mood swings, and personality changes. While there is no cure for Huntington's disease, symptoms can be managed with medications, physical therapy, occupational therapy, speech therapy, and psychological support.
Other Related Disorders
Apart from Down syndrome, Turner syndrome, and Klinefelter syndrome, many other genetic disorders are caused by chromosomal abnormalities. Examples include Fragile X syndrome, Thalassemia, Sickle cell disease, Alzheimer's disease, Schizophrenia, Cystic fibrosis, Thrombophilia, Tay Sachs Disease, Muscular Dystrophy, and Ataxia. These disorders have different types and causes of chromosomal abnormalities, such as trisomy, deletion, duplication, or imprinting. They also have varying clinical features and outcomes, such as facial anomalies, organ malformations, growth retardation, intellectual disability, behavioral problems, or increased mortality. Diagnosis of these disorders can occur through methods similar to those used for the previous three disorders, but there are no specific treatments or cures. Supportive care and symptom management, along with regular medical check-ups, are essential for individuals affected by these disorders.
References
- Alkuraya FS. Genetics and genomic medicine in Saudi Arabia. Mol Genet Genomic Med. 2014 Sep;2(5):369-78.
- Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med. 2014 Jun 19;370(25):2418-25.
- Carvalho CMB, Lupski JR. Mechanisms underlying structural variant formation in genomic disorders. Nat Rev Genet. 2016 Apr;17(4):224-38.
- Elhussein E, et al. Infertility in Africa: an overview of the current situation and future perspectives. Reprod Biomed Online. 2019 Aug;39(2):321-33.
- Gajecka M. Unrevealed mosaicism in the next-generation sequencing era. Mol Genet Genomic Med. 2016 May;4(3):240-9.
- Gao Z, et al. An estimate of the average number of recessive lethal mutations carried by humans. Genetics. 2015 Apr;199(4):1243-54.
- Gilissen C, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014 Jul 17;511(7509):344-7.
- Hickey SE, et al. Clinical application of whole-genome sequencing across the spectrum of pediatric cancer. Cold Spring Harb Mol Case Stud. 2017 Jan;3(1):a001887.
- Liu P, et al. Mechanism-based classification of genomic disorders. Am J Hum Genet. 2014 Mar 6;94(3):422-37.
- Redin C, et al. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies. Nat Genet. 2017 Jan;49(1):36-45.
- Stankiewicz P, et al. Structural variation in the human genome and its role in disease. Annu Rev Med. 2010;61:437-55.
- Yahaya TO, et al. Prevalence and risk factors of infertility among women attending a tertiary health facility in Kano, Nigeria. BMC Womens Health. 2020 Jul 13;20(1):144.
- Zhang F, et al. Complex human chromosomal and genomic rearrangements. Trends Genet. 2009 Jul;25(7):298-307.
